Product NewsMRC Technology Highlights Presentation of Data for Lambrolizumab Developed Using its Humanization Technology
Product NewsNaurex Announces Initiation of Phase I Trial for Second-Generation NOVEL ANTIDEPRESSANT AGENT NRX-1074
Product NewsAlmac Discovery Announces Licensing of ALM201 to Shin Poong for Development and Marketing in South Korea
Product NewsGenticel Secures EUR 18.2 million (USD 23.7 million) in Capital Funding to Develop Vaccines for Patients Infected with HPV
Product NewsAddex Announces Issuance of a Broad European Composition of Matter Patent for Dipraglurant
Product NewsNew Data from TIMI Study Group to Be Presented at American College of Cardiology Scientific Session Show Prognostic Value of High-Precision Cardiac Troponin Monitoring
Product NewsMersana Therapeutics Presents Positive Preclinical Data on Next-Generation Antibody-Drug Conjugate Technology at AACR 2013
Product NewsBio-Rad Launch New Bio-Plex Pro™ RBM Kidney Toxicity Panels for the Early Detection and Characterization of Kidney Toxicity and Injury During Drug Development
Product NewsMethod development to Estimate the Purity of Vesicle Preparations using Nanoparticle Tracking Analysis at the Cardiff University School of Medicine
Product NewsAddex Dipraglurant Reduces Motor Abnormalities in a Preclinical Model Relevant for Several Rare Types of Dystonia